| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Infection and Immunity, April 2007, p. 1852-1860, Vol. 75, No. 4
0019-9567/07/$08.00+0 doi:10.1128/IAI.01814-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Benaroya Research Institute at Virginia Mason, 1201 Ninth Avenue, Seattle, Washington,1 Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia,2 University of Washington School of Medicine, Seattle, Washington3
Received 15 November 2006/ Returned for modification 15 December 2006/ Accepted 22 January 2007
Detection of antigen-specific CD4+ T cells is facilitated by the use of fluorescently labeled soluble peptide-major histocompatibility complex (MHC) multimers which mirror the antigen specificity of T-cell receptor recognition. We have used soluble peptide-MHC class II tetramers containing peptides from the protective antigen (PA) of Bacillus anthracis to detect circulating T cells in peripheral blood of subjects vaccinated with an anthrax vaccine. PA-specific HLA class II-restricted T lymphocytes were isolated which displayed both TH1- and TH2-like characteristics, indicating heterogeneity of the lymphocyte lineage within the CD4+ response. Presentation of antigen to these T-cell clones by HLA-matched antigen-presenting cells exposed to the intact PA protein confirmed that the identified epitopes are indeed naturally processed by the human immune system. Specific tetramer-derived T-cell profiling may be useful for monitoring helper CD4+ T-cell responses to anthrax vaccination.
Published ahead of print on 5 February 2007.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|